Hogarty D C, Speakman E A, Puig V, Phillips M I
Department of Physiology, College of Medicine, University of Florida, Gainesville 32610.
Brain Res. 1992 Jul 24;586(2):289-94. doi: 10.1016/0006-8993(92)91638-u.
Angiotensin II (Ang II) given centrally produces an increase in blood pressure and motivation to drink. The physiological mechanisms that mediate the pressor response include release of vasopressin (AVP) and activation of the sympathetic nervous system. Using 2 new Ang II receptor antagonists, we were able to investigate the role of AT1 or AT2 receptors in mediating these effects. Adult male Sprague-Dawley rats were cannulated in the lateral ventricle and 5 days later catheterized in the carotid artery for blood pressure measurements. All experiments were carried out in conscious rats. Three treatments were given intraventricularly (i.v.t.), in 2 microliters artificial cerebrospinal fluid (ACSF) at 30 min intervals: (1) 50 ng Ang II, (2) 0.7 micrograms AT1 antagonist Losartan or 7.0 micrograms AT2 antagonist PD123177, followed by 50 ng Ang II, and (3) 50 ng Ang II, to test for recovery. Blood pressure and drinking measurements were recorded. Also, blood samples for assay of AVP were drawn at 1 or 3 min post-injection in 2 separate groups of rats. We found that both Losartan and PD123177 significantly reduced release of AVP to Ang II 1 min post-injection. Losartan significantly blocked the pressor response (P less than 0.001), while PD123177 had no significant effect. Drinking was also antagonized by Losartan (P less than 0.05) and reduced (n.s.) by PD123177. The results suggest that the pressor response to Ang II (i.v.t.) is predominantly AT1 mediated, while the drinking and AVP responses may be mediated by both receptor subtypes.
中枢给予血管紧张素II(Ang II)会使血压升高并增加饮水动机。介导升压反应的生理机制包括血管升压素(AVP)的释放和交感神经系统的激活。使用两种新型Ang II受体拮抗剂,我们能够研究AT1或AT2受体在介导这些效应中的作用。成年雄性Sprague-Dawley大鼠在侧脑室插管,5天后在颈动脉插管以测量血压。所有实验均在清醒大鼠中进行。每隔30分钟在2微升人工脑脊液(ACSF)中进行三次脑室内(i.v.t.)给药:(1)50 ng Ang II,(2)0.7微克AT1拮抗剂氯沙坦或7.0微克AT2拮抗剂PD123177,随后给予50 ng Ang II,以及(3)50 ng Ang II,以测试恢复情况。记录血压和饮水测量值。此外,在两组不同的大鼠中,在注射后1或3分钟采集血样用于检测AVP。我们发现,氯沙坦和PD123177均能显著降低注射后1分钟时AVP对Ang II的释放。氯沙坦显著阻断了升压反应(P<0.001),而PD123177没有显著作用。氯沙坦也拮抗了饮水行为(P<0.05),而PD123177使其减少(无统计学意义)。结果表明,对脑室内注射Ang II的升压反应主要由AT1介导,而饮水和AVP反应可能由两种受体亚型介导。